A simple and highly sensitive spectrofluorimetric method for the estimation of sumatriptan succinate has been investigated. The suggested method depends on the determination of the intrinsic fluorescence properties of the drug in aqueous systems at λ 350 nm following λ at 225 nm. The linearity range was 10-100 ng/ml, with a detection limit and quantitation limit of 1.2 and 3.6 ng/ml, respectively. The suggested method was sufficiently successful for determination of sumatriptan its pharmaceutical tablets as well as in spiked human plasma. Moreover, the validation parameters were determined following International Council for Harmonisation guidelines. Statistical analysis of the obtained results from the proposed and reference methods showed no significance difference between the two methods regarding accuracy and precision.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1002/bio.4000 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Activation of δ-opioid receptors blocks allodynia in a model of headache induced by PACAP.
Br J Pharmacol
January 2025
Center for Clinical Pharmacology, Department of Anesthesiology, Washington University School of Medicine, St. Louis, Missouri, USA.
Background And Purpose: Pituitary adenylate cyclase activating polypeptide (PACAP) is a human migraine trigger that is being targeted for migraine. The δ-opioid receptor (δ-receptor) is a novel target for the treatment of migraine, but its mechanism remains unclear. The goals of this study were to develop a mouse PACAP-headache model using clinically significant doses of PACAP; determine the effects of δ-receptor activation in this model; and investigate the co-expression of δ-receptors, PACAP and PACAP-PAC1 receptor.
View Article and Find Full Text PDFCurvilinear regression analysis and ranking of migraine treatment drugs using degree-based topological indices and the WASPAS method.
Comput Biol Med
January 2025
Department of Mathematics, COMSATS University Islamabad, Vehari Campus, 61100, Vehari, Pakistan. Electronic address:
Topological indices, derived from molecular graphs, provide valuable numerical descriptors for the comprehensive analysis of pharmaceuticals. These indices are pivotal in the physicochemical characterization and predictive assessment of various drugs. In this study, we calculate several degree-based topological indices for a range of migraine treatment medications, including aspirin, caffeine, eletriptan, ergotamine, sumatriptan, rizatriptan, verapamil, diclofenac, frovatriptan, and droperidol.
View Article and Find Full Text PDFMeningeal K ATP channels contribute to behavioral responses in preclinical migraine models.
Pain
February 2025
Department of Neuroscience, The Center for Advanced Pain Studies, The University of Texas at Dallas, Richardson, TX, United States.
Human experimental studies have shown that levcromakalim, an ATP-sensitive potassium (K ATP ) channel opener, induces migraine attacks in people with migraine but not in healthy volunteers. However, the exact site of action for K ATP channels in migraine pathophysiology remains unclear. This study investigates the role of these channels in the meninges in eliciting behavioral hypersensitivity responses in mice.
View Article and Find Full Text PDFA Pilot Study on the Drug Price Revision Strategy in Japan: A Comparison Among Fiscal Years 2018, 2020, and 2022.
Hosp Pharm
August 2024
Kaohsiung Medical University, Kaohsiung city, Taiwan.
Japan has resumed its health technology assessment to decide how to reduce high-cost drug prices. While drug price rules in Japan are comprehensive, they do not necessarily capture differences in product characteristics. This study examined the drug price revision strategy in Japan using migraine treatment with triptans as an example.
View Article and Find Full Text PDFPopulation pharmacokinetic modeling of zavegepant, a calcitonin gene-related peptide receptor antagonist, in healthy adults and patients with migraine.
CPT Pharmacometrics Syst Pharmacol
January 2025
Pfizer Inc., Groton, Connecticut, USA.
Article Synopsis
- Zavegepant (ZAVZPRET™) is a selective medication for treating acute migraines in adults, targeting specific receptors related to migraine pathways.
- A comprehensive analysis of its pharmacokinetics determined how zavegepant is absorbed, distributed, and eliminated from the body, utilizing data from multiple clinical trials.
- The findings revealed that zavegepant has low bioavailability rates when taken intranasally (5.1%) or orally (0.65%), with factors like age and sex not significantly affecting its pharmacokinetics, but certain conditions (like moderate liver impairment) could impact its clearance.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!